Embecta Corp. (EMBC)
USD 11.3
(-0.35%)
USD 11.3
(-0.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.03 Billion USD | 2.95% |
| 2022 | 1.97 Billion USD | 919.48% |
| 2021 | 194 Million USD | 16.87% |
| 2020 | 166 Million USD | 31.75% |
| 2019 | 126 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.96 Billion USD | -2.09% |
| 2024 Q1 | 2.01 Billion USD | -1.22% |
| 2024 Q3 | 2.03 Billion USD | 3.15% |
| 2023 Q1 | 2.03 Billion USD | 2.79% |
| 2023 FY | 2.03 Billion USD | 2.95% |
| 2023 Q4 | 2.03 Billion USD | -1.23% |
| 2023 Q3 | 2.06 Billion USD | 1.42% |
| 2023 Q2 | 2.03 Billion USD | -0.02% |
| 2022 Q4 | 1.97 Billion USD | 4.24% |
| 2022 Q2 | 1.8 Billion USD | 850.9% |
| 2022 FY | 1.97 Billion USD | 919.48% |
| 2022 Q3 | 1.89 Billion USD | 5.35% |
| 2022 Q1 | 189.4 Million USD | -2.37% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 194 Million USD | 16.87% |
| 2021 Q4 | 194 Million USD | 0.0% |
| 2020 FY | 166 Million USD | 31.75% |
| 2019 FY | 126 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | -114.806% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -22039.677% |
| Pacira BioSciences, Inc. | 704.25 Million USD | -189.114% |
| PainReform Ltd. | 2.69 Million USD | -75563.322% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -33063.398% |
| SCYNEXIS, Inc. | 55.45 Million USD | -3571.957% |
| Journey Medical Corporation | 56.49 Million USD | -3503.781% |
| Safety Shot Inc | 3.89 Million USD | -52214.414% |
| Alpha Teknova, Inc. | 38.55 Million USD | -5181.575% |
| Bright Green Corporation | 6.43 Million USD | -31525.78% |
| Procaps Group, S.A. | 462.06 Million USD | -340.652% |
| Alvotech | 1.88 Billion USD | -8.155% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | -331.676% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | -1142.244% |
| Cosmos Health Inc. | 30.25 Million USD | -6630.347% |
| Dynavax Technologies Corporation | 375.02 Million USD | -442.925% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | -208.131% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | -1387.605% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -33063.398% |
| Theratechnologies Inc. | 98.63 Million USD | -1964.194% |
| Harrow Health, Inc. | 241.75 Million USD | -742.223% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -23153.769% |
| Biofrontera Inc. | 23.13 Million USD | -8699.43% |
| DURECT Corporation | 30.4 Million USD | -6596.376% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | -317.695% |
| Cronos Group Inc. | 43.73 Million USD | -4555.424% |
| OptiNose, Inc. | 194.33 Million USD | -947.727% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | -149.104% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | -4102.911% |
| RedHill Biopharma Ltd. | 20.97 Million USD | -9605.825% |
| Organogenesis Holdings Inc. | 181.36 Million USD | -1022.672% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -53877.404% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | -3777.089% |
| Radius Health, Inc. | 804.29 Million USD | -153.155% |
| Universe Pharmaceuticals INC | 13.75 Million USD | -14703.337% |
| ProPhase Labs, Inc. | 42.54 Million USD | -4685.869% |
| Phibro Animal Health Corporation | 725.54 Million USD | -180.631% |
| Procaps Group S.A. | 462.06 Million USD | -340.652% |
| TherapeuticsMD, Inc. | 14.02 Million USD | -14420.753% |
| Viatris Inc. | 27.21 Billion USD | 92.519% |
| Rockwell Medical, Inc. | 30.88 Million USD | -6493.161% |
| Aytu BioPharma, Inc. | 90.37 Million USD | -2152.846% |
| SIGA Technologies, Inc. | 57.97 Million USD | -3411.893% |
| Tilray Brands, Inc. | 892.11 Million USD | -128.232% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | -826.342% |
| Shineco, Inc. | 47.6 Million USD | -4177.37% |
| PetIQ, Inc. | 645.22 Million USD | -215.563% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -927457.491% |
| Incannex Healthcare Limited | 5.83 Million USD | -34824.528% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | -99.735% |
| Alimera Sciences, Inc. | 107.35 Million USD | -1796.622% |
| Silver Spike Investment Corp. | 3 Million USD | -67548.316% |
| Assertio Holdings, Inc. | 148.41 Million USD | -1271.887% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -107291.223% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | -9452.082% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -28879.505% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -23880.832% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | -1074.309% |
| Hempacco Co., Inc. | 18.82 Million USD | -10717.427% |
| Talphera, Inc. | 6.29 Million USD | -32270.429% |
| Alvotech | 1.88 Billion USD | -8.155% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | -1079.664% |
| Lantheus Holdings, Inc. | 835.25 Million USD | -143.769% |
| Currenc Group, Inc. | 177.67 Million USD | -1045.964% |
| Kamada Ltd. | 109.96 Million USD | -1751.534% |
| Indivior PLC | 1.95 Billion USD | -4.349% |
| Evoke Pharma, Inc. | 9.64 Million USD | -21003.674% |
| Flora Growth Corp. | 17.22 Million USD | -11722.669% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -23880.832% |
| Evolus, Inc. | 209.68 Million USD | -871.019% |
| HUTCHMED (China) Limited | 536.38 Million USD | -279.596% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | -133.099% |
| Akanda Corp. | 12.66 Million USD | -15971.659% |